Special Invited Seminar Talk "RNA in Neuroscience" with Prof. Timothy Bredy
Please join us in person for a Special Invited Seminar Talk with Prof. Timothy Bredy
Title: RNA in Neuroscience
Date: Friday September 26, 2025, 11:00 AM
Location:聽In-person at Goodman Cancer Institute, Karp Room 501
Professor Timothy Bredy earned a PhD in Neurological Sciences from 91社区 in 2004. Following CIHR and NSERC funded postdoctoral fellowships at the University of California Los Angeles, he established his laboratory at the University of Queensland (UQ) in 2009. In 2014, he was appointed Assistant Professor at the University of California Irvine and was promoted to Associate Professor with tenure in 2016. In 2017, he returned to the Queensland Brain Institute where he is currently Professor and Founding Director of the UQ Centre for RNA in Neuroscience. Prof Bredy was awarded an ARC Australian Research Fellowship (2010-2014), a Science Without Borders Special Visiting Professorship from the Brazilian National Council for Scientific and Technological Development (2015-2017) and, more recently, an NHMRC Senior Research Fellowship (2018-2022). In 2014, he was recipient of the A.E. Bennett Research Award from the Society for Biological Psychiatry for contributions to international research by a young investigator and, in 2017, he received a NARSAD Independent Investigator Award for his work on long noncoding RNAs and memory. He is currently on the Editorial Board for the Journal of Neurochemistry and Neurobiology of Learning and Memory, and serves on Council for the Molecular and Cellular Cognition Society. Research in the Bredy laboratory is focused on understanding how the genome is connected to the environment, and how this relationship shapes brain and behaviour throughout life. The group is particularly interested in RNA-based mechanisms including non-coding RNAs and RNA modification, and how they regulate the formation and maintenance of neural plasticity and long-term fear-related memories, particularly within the context of phobia and post-traumatic stress disorder with the ultimate goal of revealing the potential of RNA-based therapeutics as an avenue toward the treatment of neuropsychiatric disorders characterized by cognitive impairment.
